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in vitro. These findings shed light to the adjustment of the 
Th17-Treg axis in response to acute Y. pseudotuberculosis 
infection and highlight the direct modulation of  CD4+ T 
cell subsets by altering their TCR downstream signaling.
Keywords Regulatory T cells · Th17 cells · Yersinia 
pseudotuberculosis · Intestinal infections · TCR signaling
Abbreviations
Y. pseudotuberculosis  Yersinia pseudotuberculosis
mLN  Mesenteric lymph node
T3SS  Type III secretion system
Yops  Yersinia outer proteins
DC  Dendritic cell
Treg  Regulatory T cell
TCR  T cell receptor
Yptb-WT  Wild-type Y. pseudotuberculosis
Ova  Ovalbumin
APC  Antigen-presenting cell
TLR  Toll-like receptor
Introduction
The intestinal immune system requires an extremely tight 
control as it is constantly exposed to high loads of harmless 
foreign antigens such as microbiota and food, while at the 
same time it has to be ready to mount rapid and efficient 
immune responses against invading pathogens. Among 
these pathogens, enteropathogenic Yersinia pseudotuber-
culosis is known to initially infect the terminal ileum and 
Peyer’s patches, followed by an entering of mesenteric 
lymph nodes (mLNs). Infections with Y. pseudotuberculosis 
frequently result in the development of diarrhea, gastroen-
teritis, and mesenteric lymphadenitis [1, 2]. Yersiniae carry 
Abstract Adaptive immunity critically contributes to 
control acute infection with enteropathogenic Yersinia 
pseudotuberculosis; however, the role of  CD4+ T cell sub-
sets in establishing infection and allowing pathogen persis-
tence remains elusive. Here, we assessed the modulatory 
capacity of Y. pseudotuberculosis on  CD4+ T cell differen-
tiation. Using in vivo assays, we report that infection with 
Y. pseudotuberculosis resulted in enhanced priming of IL-
17-producing T cells (Th17 cells), whereas induction of 
 Foxp3+ regulatory T cells (Tregs) was severely disrupted in 
gut-draining mesenteric lymph nodes (mLNs), in line with 
altered frequencies of tolerogenic and proinflammatory 
dendritic cell (DC) subsets within mLNs. Additionally, by 
using a DC-free in vitro system, we could demonstrate that 
Y. pseudotuberculosis can directly modulate T cell recep-
tor (TCR) downstream signaling within naïve  CD4+ T cells 
and Tregs via injection of effector molecules through the 
type III secretion system, thereby affecting their functional 
properties. Importantly, modulation of naïve  CD4+ T cells 
by Y. pseudotuberculosis resulted in an enhanced Th17 
differentiation and decreased induction of  Foxp3+ Tregs 
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a broad range of virulence factors allowing interaction with 
immune cells and/or mediating immune evasion. Among 
others, they encode a type III secretion system (T3SS) on 
the pYV virulence plasmid, which enables translocation of 
effector proteins (Yops, Yersinia outer proteins) through a 
needle-like structure, referred to as injectisome [3]. Upon 
delivery into target cells, Yops (including YopE, H, J/P, 
K, M, O, and T) can interfere with intracellular signaling 
events, thereby manipulating key host cell functions such as 
cytokine secretion, actin cytoskeletal rearrangements, and 
phagocytosis [4, 5]. Recently, we could demonstrate that 
efficient Yop delivery into target cells is supported by the 
cytotoxic necrotizing factor CNFγ [6].
While innate immunity represents a well-characterized 
part of the immune response against Y. pseudotuberculo-
sis, involving neutrophils, macrophages, dendritic cells 
(DCs), and natural killer cells [7–10], the role of the adap-
tive immune system in combatting invading Yersiniae is 
only incompletely understood. Besides studies underpin-
ning the importance of  CD8+ T cells in control of Yersinia 
infection [8, 11, 12], there are only few studies focusing 
on  CD4+ T helper cell responses. These studies suggest 
the involvement of IFNγ-producing proinflammatory Th1 
cells in protection against Yersinia [13], and report a capac-
ity of  CD4+ T cells in responding to Y. pseudotuberculo-
sis superantigens in an MHCII-dependent manner [14]. A 
shift from immunoregulatory  Foxp3+ regulatory T cells 
(Tregs) towards IL-17-producing proinflammatory Th17 
cells has been reported for several enteropathogenic infec-
tions [15–18]. However, only little is known whether Yers-
iniae can directly modulate differentiation of  CD4+ T cells, 
thereby favoring the establishment of infection [9, 19].
Here, we show that Y. pseudotuberculosis directly inter-
acts with  CD4+ T cells during the acute phase of infection 
and exemplify an involvement of Th17 cells and Tregs in 
the pathomechanism of disease. Using both de novo and 
in vitro T cell differentiation assays, we could demonstrate 
that T3SS-dependent modulation of T cells by Y. pseu-
dotuberculosis results in a strongly impaired induction of 
 Foxp3+ Tregs, while differentiation towards Th17 cells is 
highly supported. This immunological skewing of T cell 
differentiation is potentially mediated through the direct 
modulation of T cell receptor (TCR) downstream signaling 
pathways by the pathogen.
Materials and methods
Mouse strains
Foxp3hCD2 ×  Rag2−/−xDO11.10 (BALB/c),  Foxp3hCD2 × 
CD90.1 (BALB/c), and  Foxp3hCD2 (BALB/c) mice were 
bred and housed under specific pathogen-free conditions 
at the Helmholtz Centre for Infection Research (Braun-
schweig, Germany). BALB/c mice were purchased from 
Janvier. Gender- and age-matched mice were used in all 
experiments. Mice were housed and handled in accord-
ance with recommendations of FELASA and the national 
animal welfare body GV-SOLAS guidelines. Experimen-
tal protocols were approved by the Lower Saxony Com-
mittee on the Ethics of Animal Experiments as well as the 
responsible state office (Lower Saxony State Office of Con-
sumer Protection and Food Safety) under permit number 
33.9-42502-04-13/1240.
Antibodies and flow cytometry
Fluorochrome-conjugated anti-B220 (RA3-6B2), anti-
hCD2 (RPA-2.10), anti-CD3 (17A2), anti-CD4 (RM4-
5), anti-CD8 (53-7.3), anti-CD11b (M1/70), anti-CD11c 
(N418), anti-CD19 (6D5), anti-CD25 (PC61.5), anti-
CD49b (DX5), anti-CD86 (GL1), anti-CD103 (2E7), anti-
F4/80 (BM8), anti-Foxp3 (FJK-16S), anti-IFNγ (XMG1.2), 
anti-IL-10 (JES5-16E3), anti-IL-17 (TC11-18H10), anti-
Ly6G (1A8), anti-MHCII (M5/114.15.2), anti-pERK1/2 
(20  A), anti-RORγt (AFKJS-9), and anti-Ova-TCR (KJ1-
26) antibodies were purchased from BioLegend, eBiosci-
ence, and BD. Intracellular Foxp3/RORγt and pERK1/2 
stainings were performed according to the manufacturer’s 
instructions (Foxp3 Staining Buffer Set, eBioscience and 
Phosflow T Cell Activation Kit, BD, respectively). To 
determine the absolute number of living cells prior to flow 
cytometry analysis, propidium iodide (Sigma-Aldrich) was 
added, and cell number was determined using Accuri C6 
Cytometer (BD). Dead cells were excluded based on the 
staining with the LIVE/DEAD Fixable Blue Dead Cell 
Stain (Thermo Fisher Scientific) and scatter properties. 
Cells were analyzed on LSRFortessa (BD) with Diva soft-
ware v8.0.1 (BD), and data analysis was performed with 
FlowJo software v9.9.3 (TreeStar).
Bacterial strains
The YPIII wild-type Y. pseudotuberculosis strain (Yptb-
WT) [20] carrying the pIB1 plasmid was used throughout 
the study. The strains YP173 (Yptb-WT-Bla) and YP174 
(ΔT3SS-Bla) were constructed by chromosomal integra-
tion of the YopE-β-lactamase (ETEM) fusion plasmid 
pSR47s-E-TEM1 with Yptb-WT and the T3SS-mutant 
ΔyscS strains [6]. Overnight cultures of Yersiniae strains 
were grown at 25 °C in Luria–Bertani broth medium (BD), 
washed, and diluted in PBS prior to infection. For in vitro 
co-culture experiments, bacteria were diluted 1:50 after 
overnight incubation, followed by incubation for 2  h at 
25 °C and additional cultivation for 3  h at 37 °C. 50  μg/
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ml kanamycin (Sigma-Aldrich) was used for bacterial 
selection.
Mouse infection
Female BALB/c mice (Janvier) aged between 6 and 
7 weeks were subjected to fasting for 16 h prior to infec-
tion. Subsequently, mice were orally infected with 2 × 108 
Yptb-WT using a ball-tipped gavaging needle. 2  days 
p.i., the frequency of neutrophils in the peripheral blood 
of infected and non-infected mice was analyzed by flow 
cytometry, and significantly increased mobilization of neu-
trophils into peripheral blood of infected mice was taken 
as an indicator of a successful infection (data not shown). 
In general, body-weight loss and signs of severe illness of 
mice infected with 2 × 108 Yptb-WT peaked at day 5–6. At 
indicated time points p.i., infected mice were analyzed or 
subjected to further experimental procedures.
In vivo T cell differentiation assay
For adoptive transfer, single cell suspensions were generated 
from spleens and LNs of  Foxp3hCD2xRag2−/−xDO11.10 
mice. Before transfer, cells were labeled with the prolif-
eration dye Cell Trace™ Violet (CTV, Thermo Fisher Sci-
entific), and 4 × 106 cells were injected in 100 µl PBS i.v. 
per recipient mouse. For induction of T cell differentiation, 
20 µg  Ova323–339 peptide was injected i.v. on two consecu-
tive days, starting 1  day after adoptive T cell transfer. At 
day 3 after the first antigen application, cells were isolated 
from mLNs and stained for flow cytometric analysis. Intra-
cellular cytokine staining was performed after restimula-
tion with phorbol 12-myristate 13-acetate (PMA)/ionomy-
cin for 2 h (10 and 500 ng/ml, respectively) and with 10 μg/
ml Brefeldin A for additional 2 h at 37 °C (all from Sigma-
Aldrich), followed by fixation and standard staining of sur-
face markers.
Field emission scanning electron microscopy (FESEM)
Total  CD4+ T cells were enriched from spleens and LNs 
of BALB/c mice using CD4 (L3T4) MicroBeads and 
autoMACS separation (Miltenyi Biotec).  CD4+ T cells 
were co-cultured with Yptb-WT for 1 h at MOI (multiplic-
ity of infection) 100, followed by washing. Fixation was 
performed by 1  h incubation and washing with cacodylat 
buffer. Cells were placed on poly-l-lysine-coated cover 
slips, followed by fixation with 3% glutaraldehyde and 
washed with TE-buffer (0.02 M Tris, 0.001 M EDTA, pH 
7.0), dehydrated with a graded series of acetone (10, 30, 
50, 70, 90, 100%), and critical-point dried. After sputter 
coating with a gold film (appr. 10 nm), samples were ana-
lyzed using a Zeiss DSM 982 Gemini FESEM.
β‑Lactamase reporter assay
For in  vivo analysis of Yop translocation, BALB/c mice 
were infected intragastrically with 2 × 109 Yptb-WT-Bla. 
At day 3, single cell suspensions of mLNs were stained 
for cell surface markers and subsequently labeled with 
CCF4-AM, using the LiveBLAzer-FRET B/G Load-
ing Kit (Thermo Fisher Scientific) for 1  h at room tem-
perature in the presence of 1.5  mM probenecid (Sigma-
Aldrich) and 50  μg/ml gentamicin (Sigma-Aldrich). To 
study Yop translocation in  vitro, naïve  CD4+ T cells 
were isolated from spleen and LNs of  Foxp3hCD2 mice. 
Briefly, cells were stained with anti-CD25-APC and anti-
hCD2-APC, followed by a depletion of  APC+ cells using 
anti-APC MicroBeads (Miltenyi Biotec) and autoMACS 
separation system. Subsequently,  CD4+ T cells were mag-
netically sorted as described before. The resulting naïve 
 Foxp3hCD2−CD62LhiCD44loCD25−  CD4+ T cells were co-
cultured with Yptb-WT-Bla or ΔT3SS-Bla at an MOI of 10 
for 1  h at 37 °C, washed twice with RPMI supplemented 
with 50  μg/ml gentamicin to eliminate bacteria. Subse-
quently, 2 × 106 cells were labeled with CCF4-AM and ana-
lyzed by flow cytometry.
Ca2+ signaling measurement
Total  CD4+ T cells were enriched from spleens and LNs 
of  Foxp3hCD2 mice via autoMACS separation. MACS-sep-
arated  CD4+ T cells were co-cultured with Yptb-WT-Bla 
and ΔT3SS-Bla strains at MOI of 50 for 1 h at 37 °C and 
washed twice with gentamicin-containing RPMI. Subse-
quently, cells were stained for CD4 and  Foxp3hCD2, loaded 
with 4  μg/ml Indo-1 AM cell permanent dye (Thermo 
Fisher Scientific) at 37 °C for 45 min in dark, followed by 
pre-decoration with 18  μg/ml anti-CD3-Biotin and 1  μg/
ml anti-CD28-Biotin (both from BD). TCR crosslink-
ing was induced by the addition of 40 μg/ml Streptavidin 
(Dianova) to the pre-warmed cell suspension. Ionomycin 
at 4 μg/ml concentration served as positive control provid-
ing maximum  Ca2+ influx. The  Ca2+ signal was measured 
in the respective gates of Tregs and naïve T cells by flow 
cytometry.
pERK staining
Total  CD4+ T cells were enriched from spleens and LNs 
of  Foxp3hCD2 mice by autoMACS separation. MACS-sep-
arated  CD4+ T cells were co-cultured with Yptb-WT-Bla 
and ΔT3SS-Bla strains at MOI of 50 for 1 h at 37 °C and 
washed twice with gentamicin-containing RPMI. Subse-
quently, cells were first stained with LIVE/DEAD Fixable 
Blue Dead Cell Stain and anti-CD4 antibody, followed by 
decoration with 10  μg/ml anti-CD3-Biotin and 5  μg/ml 
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anti-CD28-Biotin antibodies for 15 min on ice. Crosslink-
ing was induced by the addition of 10 μg/ml Streptavidin to 
the pre-warmed cell suspensions. At indicated time points, 
cells were fixed and permeabilized, followed by intracellu-
lar staining with anti-pERK1/2 and anti-Foxp3 antibodies 
overnight at 4 °C. Next, ERK phosphorylation was deter-
mined in the respective gates of live  CD4+Foxp3 naïve T 
cells and  CD4+Foxp3+ Tregs.
In vitro T cell differentiation assay
Naïve  CD4+ T cells were isolated from spleen and LNs of 
 Foxp3hCD2 mice as described before. The resulting naïve 
 Foxp3hCD2−CD62LhiCD44loCD25−  CD4+ T cells were co-
cultured with Yptb-WT-Bla and ΔT3SS-Bla at an MOI of 
50 for 1 h at 37 °C. After the removal of bacteria by wash-
ing with gentamicin-containing RPMI, cells were cultured 
under Th0, Th1, Th17, or Treg-polarizing conditions. For 
Treg cultures, 5 × 105 cells/well were cultured on 96-well 
round-bottom plates in RPMI supplemented with 10  ng/
ml IL-2 (R&D), 5  ng/ml TGF-β1 (R&D), 50  μg/ml gen-
tamicin, and anti-CD3/CD28 Dynabeads Mouse T Acti-
vator (Thermo Fisher Scientific) at 1:1 ratio. Frequency 
of  Foxp3hCD2+ cells was determined 4  days later. For 
Th17 culture conditions, 2 × 106 cells/well were cultured 
in 24-well plates coated with 3  μg/ml anti-CD3 (BioLeg-
end) and 5 μg/ml anti-CD28 (eBioscience) in IMDM sup-
plemented with 2 ng/ml TGF-β1, 30 ng/ml IL-6, 10 ng/ml 
IL-1β, 5 μg/ml anti-IL-2, 20 ng/ml TNF-α (all from Bio-
Legend), 10  μg/ml anti-IFN-γ (BioXCell), and 50  μg/ml 
gentamicin for 4  days. Then, cells were replated in fresh 
medium and cultured without TCR stimulation for two 
additional days. On day 6, frequency of IL-17+ cells was 
determined after restimulation and fixation as described 
before. For Th0 and Th1 cultures conditions, 2 × 106 cells/
well were cultured in 24-well plates coated with 2  μg/ml 
anti-CD3 and anti-CD28 in IMDM containing 50  μg/ml 
gentamicin. The Th1 culture medium was supplemented 
with 20  ng/ml IL-12 (PeproTech) and 10  μg/ml anti-IL-4 
(BioLegend), whereas cells cultured under Th0 conditions 
did not receive any cytokines or neutralizing antibodies. 
Cells were replated in fresh medium on day 2 and cultured 
without TCR stimulation for three additional days. On day 
5, frequency of IFN-γ+ cells was determined after restimu-
lation and fixation, as described before.
Statistical analysis
Group sizes were estimated according to a presumed stand-
ard deviation (SD) and an expected type I error of <0.05. 
The sample size was adjusted, if required, based on ini-
tial results. For all figures, each data point represents a 
single mouse if not stated otherwise. For comparison of 
unmatched groups, two-tailed Mann–Whitney statistical 
test was applied. The comparison of more than two groups 
was performed by one-way ANOVA followed by Bonferro-
ni’s post-test. All data are presented as mean or mean ± SD, 
and p values < 0.05 are considered as significant (*p < 0.05; 
**p < 0.01; ***p < 0.001; ****p < 0.0001). Prism software 
(GraphPad, La Jolla, CA, USA) was applied for all statisti-
cal analyses and graphs.
Results
Acute Y. pseudotuberculosis infection impairs de novo 
Treg induction and favors Th17 differentiation
The role of immunoregulatory  Foxp3+ Tregs and proin-
flammatory Th17 cells in combatting acute Yersiniae infec-
tions is only incompletely understood [9, 19]. Thus, we first 
assessed whether acute infection with Y. pseudotuberculosis 
has an effect on the peripheral de novo generation of these 
two opposing T cell subsets. Since gut-draining mLNs are 
among the first target organs of Y. pseudotuberculosis, we 
decided to focus on T cell differentiation events taking 
place within mLNs. Thereto, BALB/c mice were infected 
sublethally with wild-type Y. pseudotuberculosis (Yptb-
WT). At day 2 post infection (p.i.), shortly before the infec-
tion reaches its peak, TCR-transgenic, ovalbumin (Ova)-
specific naïve  Foxp3−CD4+ T cells were labeled with a cell 
proliferation dye and adoptively transferred into infected 
mice, while uninfected recipient mice served as controls 
(Fig. 1a). Subsequently, adoptively transferred naïve T cells 
were primed by systemic application of Ova peptide via the 
i.v. route on two consecutive days as reported previously 
[21]. At day 3 after the first antigen application, prolifer-
ating Ova-specific T cells within mLNs of uninfected and 
Yptb-WT-infected mice were analyzed by flow cytometry 
(Fig. 1b, c). As expected from previous observations [21], 
a high frequency of de novo-induced  Foxp3+ Tregs among 
adoptively transferred T cells was observed in mLNs of 
uninfected mice. Importantly, de novo Treg induction was 
dramatically reduced in mLNs of mice infected with Yptb-
WT (Fig. 1b). In parallel, the frequency of IL-17-produc-
ing cells among adoptively transferred Ova-TCR+CD4+ T 
cells, albeit being at a low level, was significantly higher 
upon infection with Yptb-WT when compared to unin-
fected controls (Fig. 1c), in line with a significant increase 
in IL-17-producing endogenous  CD4+ T cells at day 8 
p.i. (Supplementary Fig. S1). In contrast to this increase 
in IL-17-producing T cells, the frequency of IFN-γ- and 
IL-10-producing endogenous  CD4+ T cells remained 
unchanged during the first 12 days p.i. (Supplementary Fig-
ure S1), further supporting the important contribution of 
Th17 cells to the control of Y. pseudotuberculosis infection 
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[22]. Together, these results indicate that acute Y. pseudo-
tuberculosis infection shifts the immunological balance 
from immunoregulatory towards proinflammatory T cells, 
thereby favoring the establishment of a protective, inflam-
matory environment in the intestine.
Yersinia pseudotuberculosis infection alters composition 
of the DC compartment
It is widely accepted that DCs play a key role for de novo 
induction of both  Foxp3+ Tregs [21, 23] and Th17 cells 
[24]. Since gastrointestinal inflammation can strongly 
modify the DC compartment within mLNs, resulting in 
reduced tolerogenic properties of DCs [25], we next aimed 
to explore whether DC subsets were substantially altered 
within mLNs during acute infection with Y. pseudotuber-
culosis, and might contribute to the observed shift from 
Tregs to Th17 cells. At day 5 p.i., the overall frequency of 
 MHCIIhiCD11chi conventional DCs (cDCs) was strongly 
reduced in mLNs of mice infected with Yptb-WT (Supple-
mentary Fig. S2a, b). However, absolute numbers of cDCs 
within mLNs did not change significantly when compar-
ing infected mice to uninfected controls (Supplementary 
Fig. S2c). Nevertheless, we could observe a substantial 
alteration among specialized subsets within the cDC com-
partment. Tolerogenic  CD103+CD8+ cDCs, known to be 
involved in de novo Treg induction [21, 23, 26, 27], were 
strongly reduced upon infection with Yptb-WT, whereas 
 CD103−CD8− cDCs, which have been described to be 
responsible for priming of Th1 and/or Th17 cells [24], 
were significantly expanded (Fig.  2a–c). Importantly, 
 CD103−CD8− cDCs displayed a strong increase in CD86 
expression upon infection with Yptb-WT (Fig.  2d, e), 
reflecting their activated phenotype. Taken together, acute 
Y. pseudotuberculosis infection strongly affects the cDC 
compartment, and leads to a partial contraction of tolero-
genic  CD103+CD8+ cDCs, which might be responsible for 
the observed reduction of de novo Treg induction, while 
the expansion of  CD103−CD8− cDCs supports our initial 
observation of a shift towards Th17 differentiation.
Yersinia pseudotuberculosis directly targets  CD4+ T cell 
subsets
Our hitherto existing results suggested that acute Y. pseu-
dotuberculosis infection causes an alteration of the Th17-
Treg balance by strongly affecting the cDC compartment. 
However, in addition to these indirect effects on T cell dif-
ferentiation, more direct effects on T cell fate decisions are 
conceivable. Thus, we next asked whether Y. pseudotuber-
culosis could also directly interact with  CD4+ T cells. At 
first, we performed field emission scanning electron micros-
copy analyses after co-culturing naïve  CD4+ T cells with 
Yptb-WT in vitro and observed a direct attachment of Yers-
iniae to naïve T cells (Fig. 3a). In order to identify  CD4+ 
T cell subsets being targeted by Y. pseudotuberculosis, we 
next applied a β-lactamase reporter assay [28, 29]. To this 
end, a Yptb-WT strain variant was generated via chromo-
somal integration of a YopE-β-lactamase fusion plasmid. 
This strain, named Yptb-WT-Bla, allows the assessment of 
Yop translocation into cells loaded with the cell permeable, 
β-lactamase-sensitive dye CCF4-AM [28, 29], resulting in 
a fluorescence shift from green to blue (Fig. 3b). In vitro 
co-culture of  CD25hiCD4+ Tregs with Yptb-WT-Bla 
resulted in slightly higher translocation frequency as com-
pared to naïve  CD4+ T cells (data not shown). To moni-
tor in vivo Yop translocation and to identify  CD4+ T cell 
subsets being modulated by Y. pseudotuberculosis, BALB/c 
mice were infected sublethally with Yptb-WT-Bla. At day 
3 p.i., the frequency of modulated cells among naïve  CD4+ 
T cells and  CD25hiCD4+ Tregs from mLNs was analyzed 
































































Fig. 1  Abrogation of de novo Treg induction and increased Th17 dif-
ferentiation during acute Y. pseudotuberculosis infection. a BALB/c 
mice were infected with 2 × 108 Yptb-WT, and received 4 × 106 CTV-
labeled cells from  Foxp3hCD2xRag2−/−xDO11.10 mice 2  days p.i. 
Uninfected mice were taken as controls. On the following 2  days, 
recipients were immunized via i.v. injection of  Ova323-339 peptide and 
analyzed on day 3 after the first immunization by flow cytometry. b, 
c Representative dot plots show expression of Foxp3 b or IL-17 c 
over cell division (as indicated by loss of CTV) on adoptively trans-
ferred  CD4+Ova-TCR+ T cells in mLN from Yptb-WT-infected mice 
or uninfected controls. Numbers indicate frequencies of cells in gates. 
Scatter plots summarize frequencies of  Foxp3+ (b) or  IL17+ (c) cells 
among adoptively transferred  CD4+Ova-TCR+ T cells from indicated 
groups. Data are pooled from three independent experiments, each 
with 3–5 mice per group. ****p < 0.0001
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Fig. 2  Acute Y. pseudotuberculosis infection results in decreased 
frequencies of tolerogenic  CD103+CD8+ DCs, and expansion of 
proinflammatory  CD103− DCs. BALB/c mice were infected with 
2 × 108 Yptb-WT, and on day 5 p.i. cDC subsets within mLNs were 
analyzed by flow cytometry. Uninfected mice were taken as con-
trols. a Representative dot plots depict CD8 and CD103 expression 
of  Lin−(CD3−CD19−CD49b−B220−)CD11chiMHCIIhi cDCs in mLN 
from Yptb-WT-infected mice or uninfected controls. Numbers indi-
cate frequencies of cells in gates. b, c Scatter plots summarize the 
frequencies of  CD103+CD8+ cells (b) and  CD103−CD8− cells (c) 
among cDCs from indicated groups. d Representative histograms 
depict CD86 expression of  CD8−CD103− cDC subset from indicated 
groups. The region was set according to isotype control staining, and 
numbers indicate frequencies of  CD86+ cells. e Scatter plot summa-
rizes frequencies of  CD86+ cells among  CD8−CD103− cDC subset 
from indicated groups. Data are pooled from two independent experi-




































Fig. 3  Y. pseudotuberculosis directly targets  CD4+ T cell subsets. a 
Scanning electron microscopy of unmodulated and Yptb-WT-mod-
ulated naïve  CD4+ T cells; representative pictures taken from one 
experiment. b Scheme of the β-lactamase reporter assay: upon Yop 
translocation into cells loaded with CCF4-AM, the β-lactamase-
sensitive dye is cleaved, resulting in a fluorescence shift from green 
to blue. c Scatter plot depicts frequency of Y. pseudotuberculosis-
modulated  CD25−CD4+ naïve T cells and  CD25hiCD4+ Tregs in 
mLNs assessed 3  days after intragastric infection of BALB/c mice 
with 2 × 109 Yptb-WT-Bla. Data are pooled from two independent 
experiments, each with 6–7 mice per group. **p < 0.01. d Ex  vivo-
isolated naïve  CD4+ T cells were co-cultured with Yptb-WT-Bla or 
ΔT3SS-Bla for 1 h or were left unmodulated as control. The frequen-
cies of Y. pseudotuberculosis-modulated cells were analyzed by flow 
cytometry utilizing the β-lactamase reporter assay. Representative 
dot plots demonstrate the shift in fluorescence from green to blue in 
Yptb-WT-Bla-modulated cells (middle panel), or lack of blue cells in 
unmodulated and ΔT3SS-Bla-modulated cells (left and right panels, 
respectively)
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that the frequency of in vivo-modulated Tregs, albeit being 
at a low level, was significantly higher when compared to 
naïve  CD4+ T cells (Fig. 3c). To assess the role of the T3SS 
in modulating  CD4+ T cells, a variant of the ΔyscS T3SS 
mutant strain [6], named ΔT3SS-Bla, was generated via 
chromosomal integration of the YopE-β-lactamase fusion 
plasmid. After in  vitro co-culture of naïve  CD4+ T cells 
with ΔT3SS-Bla, all modulated cells fully retained their 
green fluorescence, in contrast to Yptb-WT-Bla-modulated 
cells showing a substantial fraction of blue cells (Fig. 3d). 
In conclusion, the β-lactamase reporter assay enabled to 
demonstrate direct targeting of  CD4+ T cell subsets, par-
ticularly Tregs, by Y. pseudotuberculosis in vivo. Moreover, 
the ΔT3SS-Bla strain proved to be helpful to further dis-
sect alterations in T cell functional properties affected by 
the T3SS.
Yersinia interferes with TCR‑induced  Ca2+ signaling 
and ERK phosphorylation within both naïve T cells 
and Tregs
As translocation of Yops can modulate host cell signaling 
responses [4], we next aimed to unravel downstream events 
of TCR signaling influenced by Y. pseudotuberculosis. 
First, we analyzed intracellular  Ca2+ flux in  CD4+ T cells 
stimulated via their TCR by using Indo-1 AM cell permea-
ble dye as a rapid and sensitive measure of TCR activation. 
TCR crosslinking was induced via the addition of streptavi-
din to cells pre-decorated with biotinylated anti-CD3/CD28 
antibodies. Similar to what has been reported before [30], 
TCR-triggered  Ca2+ signaling of naïve  CD4+ T cells was 
profoundly higher as compared to  Foxp3+ Tregs (Fig. 4a). 
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Fig. 4  Y. pseudotuberculosis modulates naïve T cells and Tregs by 
interfering with TCR downstream signaling pathways.  CD4+ T cells 
were enriched from secondary lymphoid organs of  Foxp3hCD2 mice 
and co-cultured with Yptb-WT-Bla or ΔT3SS-Bla for 1  h. Subse-
quently, TCR crosslinking of anti-CD3/CD28 pre-decorated cells was 
induced by addition of streptavidin (Str). a Intracellular  Ca2+ flux 
was assessed in  Foxp3hCD2− naïve T cells and  Foxp3hCD2+ Tregs by 
flow cytometry using the cell permeable Indo-1 AM dye.  Ca2+ flux 
in response to the positive control ionomycin (Iono) was equivalent 
between all groups. Histograms show representative results of three 
independent experiments. b Phosphorylation of ERK was assessed 
1.5  min after TCR crosslinking by intracellular pERK staining and 
flow cytometry in  Foxp3hCD2− naïve T cells and  Foxp3hCD2+ Tregs. 
Representative histograms depict pERK expression of gated cells 
from indicated groups, and numbers indicate frequencies of  pERK+ 
cells. The region was set according to isotype control staining of 
unmodulated cells (upper left). Stimulation of cells with PMA plus 
Iono served as positive control (upper right). c Scatter plots summa-
rize frequencies of  pERK+ cells among  Foxp3hCD2− naïve  CD4+ T 
cells (left) and  Foxp3hCD2+ Tregs (right). Data are pooled from four 
independent experiments. Ns not significant; *p < 0.05; **p < 0.01
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 CD4+ T cells showed a strong reduction in  Ca2+ signaling, 
while  Ca2+ flux into  Foxp3+ Tregs even was completely 
blocked. This interference with TCR-induced  Ca2+ signal-
ing was strictly dependent on the T3SS as modulation of 
 CD4+ T cells with ΔT3SS-Bla did not alter  Ca2+ signal-
ing within both  CD4+ T cells and  Foxp3+ Tregs (Fig. 4a), 
suggesting that translocation of Yops critically contribute 
to the modulation of TCR downstream signaling. Sec-
ondly, we measured TCR-induced phosphorylation of ERK 
(pERK), a more specific indicator of TCR activation, after 
the modulation of naïve  CD4+ T cells with Y. pseudotuber-
culosis. Kinetic studies (0–5  min after TCR crosslinking) 
revealed that the peak of ERK phosphorylation occurred 
after 1.5  min (data not shown), and this time point was 
chosen for all further analyses. In accordance with pub-
lished data [30], unmodulated naïve  CD4+ T cells showed 
a higher frequency of  pERK+ cells as compared to unmod-
ulated  Foxp3+ Tregs, while both cell types showed strong 
pERK activation upon stimulation with PMA and ionomy-
cin (Fig. 4b). Upon modulation with Yptb-WT, ERK phos-
phorylation was completely abrogated in both naïve  CD4+ 
T cells and  Foxp3+ Tregs, and again this interference with 
TCR-induced signaling was strictly dependent on the T3SS 
as modulation of  CD4+ T cells with ΔT3SS-Bla did not 
result in a reduced ERK phosphorylation in any of the two 
T cell subsets (Fig. 4b, c). Together, our data suggest that Y. 
pseudotuberculosis can directly interfere with TCR down-
stream signaling in both naïve  CD4+ T cells and  Foxp3+ 
Tregs, most likely through translocation of Yops in a T3SS-
dependent manner.
Modulation of naïve T cells with Y. pseudotuberculosis 
supports the differentiation of Th17 cells, but disturbs 
de novo induction of  Foxp3+ Tregs
Having demonstrated that Y. pseudotuberculosis can 
directly modulate early events of TCR downstream sign-
aling, we next asked which consequences this modulation 
might have on de novo generation of Th17 cells and  Foxp3+ 
Tregs. To this end, ex  vivo-isolated naïve  CD4+ T cells 
were co-cultured with Yptb-WT-Bla or ΔT3SS-Bla for 1 h, 
followed by gentamicin treatment to kill living bacteria. 
Subsequently, modulated naïve  CD4+ T cells were stimu-
lated in vitro in an antigen-presenting cell (APC)-free sys-
tem under polarizing conditions. Stimulation of Yptb-WT-
Bla-modulated naïve  CD4+ T cells under Th17-polarizing 
conditions resulted in a significantly enhanced frequency of 
IL-17+ cells at day 6 of the culture when compared to dif-
ferentiation of unmodulated naïve  CD4+ T cells (Fig. 5a), 
although expression of the lineage specification transcrip-
tion factor RORγt remained unaffected (Supplementary 
Fig. S3). Importantly, this enhanced Th17 differentiation 
was strictly dependent on the T3SS as modulation of  CD4+ 
T cells with ΔT3SS-Bla did not result in an increased fre-
quency of Th17 cells.
The opposite was observed when Yptb-WT-Bla-mod-
ulated naïve  CD4+ T cells were stimulated under Treg-
inducing conditions. Here, we saw a significantly reduced 
frequency of  Foxp3+ Tregs at day 4 of the culture when 
compared to differentiation of unmodulated naïve  CD4+ T 
cells (Fig.  5b). Also this disturbance of in  vitro Treg dif-
ferentiation was dependent on the T3SS as no impact could 
be observed upon modulation of naïve  CD4+ T cells with 
ΔT3SS-Bla (Fig.  5b). Importantly, Y. pseudotuberculosis 
did not modulate the capacity of naïve  CD4+ T cells to dif-
ferentiate into IFN-γ-producing cells as no difference in 
frequencies of IFN-γ+ cells was observed in Th0 or Th1 
cultures when Yptb-WT-Bla-modulated naïve  CD4+ T cells 
were directly compared with unmodulated cells (Supple-
mentary Fig. S4).
Together, these in  vitro data suggest that the direct 
T3SS-dependent modulation of TCR downstream signaling 
within naïve  CD4+ T cells alters their differentiation poten-
tial, resulting in a skewing from suppressive  Foxp3+ Tregs 
to proinflammatory Th17 cells.
Discussion
In the intestine, the balance between effector and regulatory 
pathways needs to be tightly controlled in order to main-
tain immune homeostasis and efficiently combat infections. 
Therefore, the ability of  CD4+ T cells to change their phe-
notype and to acquire special functional properties might 
be critical during acute infection with enteropathogenic Y. 
pseudotuberculosis. Here, we report that Yersiniae selec-
tively disrupt the balance between Tregs and Th17 cells, 
towards an increased differentiation of proinflammatory 
Th17 cells and a reduction in the generation of immunosup-
pressive Tregs, whereas the frequency of IFN-γ-producing 
Th1 cells or IL-10-producing T cells remained largely 
unaltered. The Yersinia-mediated support of proinflamma-
tory responses is surprising as pathogenic bacteria usually 
promote Treg expansion, enabling their long-term survival 
in the host and establishment of chronic infection [31, 32]. 
However, Yersiniae rather impair efficient de novo Treg 
induction within gut-draining mLNs, potentially favoring 
systemic dissemination of the pathogen [17]. Furthermore, 
increased de novo generation of Th17 cells could support 
the pathogen in establishing an inflammatory environment 
via altering microbiota composition, thereby favoring colo-
nization of Y. pseudotuberculosis, similar to changes insti-
gated by Citrobacter rodentium and Salmonella infections 
[33, 34]. On the other hand, the relatively late appearance 
of endogenous Th17 cells argues against a microbiota-
induced ‘innate-like’ character, which had been reported 
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previously [35], but rather suggests that these Th17 cells 
are pathogen-specific. Thus, our data represent first evi-
dence that Yersiniae disrupt the Th17-Treg balance, which 
might be a critical strategy of the pathogen in establishing 
acute infection.
To better understand how Yersiniae fine-tune the  CD4+ 
T cell compartment, we characterized DC subsets within 
mLNs during acute infection. It had been shown before that 
inflammatory conditions within the gut not only alter the 
distribution of DCs [36, 37], but also negatively affect the 
tolerogenic  CD103+ subset [25], which is known to effi-
ciently promote de novo generation of  Foxp3+ Tregs [23, 
26]. Therefore, we first hypothesized that Y. pseudotuber-
culosis indirectly affects T cell differentiation via modu-
lation of DC subsets within mLNs. Indeed, the strongly 
decreased frequency of tolerogenic  CD103+CD8+ DCs 
could account for reduced Treg induction [23, 24, 38], 
although it cannot be formally excluded that the reduced 
frequency of  CD103−CD8+ DCs, which most probably 
belong to resident DCs [27] and for which a tolerogenic 
phenotype has been described before [39], are also respon-
sible. In contrast, expansion of the CD103 DC subset 
might be responsible for increased differentiation of Th17 
cells [24, 40]. Interestingly, in a recently published study 
chronic infection with Y. pseudotuberculosis only resulted 
in a decreased frequency of  CD103+CD11b+ DCs, without 
affecting any other DC subsets [9]. This is in contrast to 
data from the present study, where during the acute phase 
of infection, frequencies of both  CD103+ and  CD103− DCs 
were altered by enteropathogenic Yersiniae, and most likely 
these changes jointly contribute to the establishment of a 
strong inflammatory response. Moreover, increased CD86 
expression levels of the latter DC subset demonstrate their 
highly activated status and suggest the possible involve-
ment of Toll-like receptors (TLRs) in creating a shift 
towards Th17-dominated immune responses [41–43]. How-
ever, it still needs to be investigated whether TLR agonists 
of Y. pseudotuberculosis contribute to the increased Th17 
differentiation.
Nonetheless, Yersiniae cannot only affect the DC com-
partment. Using the β-lactamase reporter system, we could 
demonstrate that upon infection via the natural route Yers-
iniae can directly modulate  CD4+ T cells within infected 
mLNs, extending previous findings from a systemic infec-
tion model [29]. Interestingly, within the  CD4+ T cell 
population, Tregs were preferentially modulated when 
compared to naïve T cells. The increased translocation 
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Fig. 5  In vitro modulation of naïve T cells with Y. pseudotuberculo-
sis results in increased differentiation of Th17 cells and decreased de 
novo induction of  Foxp3+ Tregs. Naïve  CD4+ T cells were enriched 
from secondary lymphoid organs of  Foxp3hCD2 mice and co-cultured 
with Yptb-WT-Bla or ΔT3SS-Bla for 1 h, or were left unmodulated 
as control. Subsequently, modulated T cells were cultured under 
Th17-polarizing or Treg-inducing conditions for 6 or 4 days, respec-
tively, and IL-17 or Foxp3 expression was assessed by flow cytometry 
at the end of the cultures. Representative dot plots show expression 
of IL-17 (a) and Foxp3 (b) in cells from indicated cultures. Numbers 
indicate frequencies of cells in gates. Scatter plots summarize fre-
quencies of IL-17+ (a) and  Foxp3+ (b) cells from indicated cultures. 
Data are pooled from six (a) or seven b independent experiments, 
and means of technical replicates are depicted. *p < 0.05; **p < 0.01; 
****p < 0.0001
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Y. pseudotuberculosis invasin to β1 integrin VLA4 [44], 
which is expressed at higher levels in Tregs as compared to 
naïve T cells [45].
When dissecting the mechanism of Yersiniae-dependent 
Treg modulation and alteration of naïve T cell differen-
tiation, we observed a stark decline of  Ca2+ mobilization 
after TCR triggering for naïve  CD4+ T cells, while  Ca2+ 
signaling within  Foxp3+ Tregs was even fully abrogated. 
In line with reduced  Ca2+ mobilization, phosphoryla-
tion of ERK was strongly abolished in both naïve  CD4+ 
T cells and  Foxp3+ Tregs. Since ΔT3SS-Bla affected nei-
ther  Ca2+ signaling nor ERK phosphorylation within both 
cell types, our findings indicate that direct modulation of 
T cells requires the presence of the T3SS. The importance 
of Yop translocation was also suggested from results of 
the APC-independent, in vitro T cell differentiation assay, 
where increased frequencies of Th17 cells and reduced de 
novo Treg induction were observed only upon co-culture of 
naïve T cells with Yptb-WT and not with T3SS-deficient 
Yersiniae. Among Yops, the tyrosine phosphatase YopH 
is known to interfere with early T cell receptor signaling 
events, either via direct phosphorylation of signaling mol-
ecules [46–48], or by binding to adaptor proteins, which 
then target them to signaling complexes [48, 49]. Thus, 
YopH might be responsible for the reduced  Ca2+ mobili-
zation and ERK phosphorylation we observed in  CD4+ 
T cell subsets being modulated by Y. pseudotuberculosis. 
Moreover, ERK activity in Jurkat T cells had been restored 
by addition of a YopH inhibitor [50], further arguing for 
the involvement of YopH in the reduction of ERK phos-
phorylation of both naïve  CD4+ T cells and  Foxp3+ Tregs. 
Additionally, the interference of YopH with TCR signaling 
could also lead to reduced secretion of IL2 [47, 51]. Since 
IL-2 is a factor critically required for induction of Tregs 
and at the same time can prevent Th17 differentiation [52, 
53], it is tempting to speculate that Y. pseudotuberculosis-
mediated alterations in IL-2 production also contribute to 
the skewing from Tregs to Th17 cells, and the lower fre-
quency of de novo-induced Tregs might enable enhanced 
generation of Th17 cells. Yet, whether YopH is the master 
regulator of Y. pseudotuberculosis-mediated modulation of 
T cell differentiation or other mechanisms contribute to the 
fine-tuning of the closely related transcriptional regulation 
of Tregs and Th17 cells [54, 55] remains to be elucidated. 
In this context, it will be also interesting to dissect why 
modulation of naïve  CD4+ T cells with Yptb-WT-Bla did 
only affect expression of the cytokine IL-17 in Th17-polar-
izing cultures, but not the expression of the Th17 lineage 
specification factor RORγt, although under Treg-inducing 
conditions a severe impact on the expression of the Treg 
lineage specification factor Foxp3 could be observed.
Taken together, the present study implicates a criti-
cal role of  CD4+ T cell subsets in the pathomechanism of 
acute Y. pseudotuberculosis infection, showing that this 
enteropathogen favors the generation of Th17 cells, and 
in parallel leads to a decline in Treg induction. Our data 
provide evidence that Y. pseudotuberculosis interferes with 
TCR signaling in both  Foxp3+ Tregs and naïve  CD4+ T 
cells, thereby directly modulating T cell-mediated immune 
responses. Efforts to understand the precise pathomecha-
nism of gastric infections could permit the development 
of future therapeutics for an efficient modulation of the 
immune system.
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